Team
health

GRACE Calculator

The GRACE score quantifies short-term mortality risk for patients presenting with acute coronary syndrome. Cardiologists and emergency physicians use this evidence-based tool to stratify risk across two time windows: during hospitalization and within six months of admission. Derived from a multinational registry spanning over 100,000 ACS cases, the score integrates clinical presentation, vital signs, and laboratory findings into a single prognostic metric that guides clinical decision-making and resource allocation.

Last updated:

Creators Małgorzata Koperska, MD
5,824 people find this calculator helpful

Understanding the GRACE Score

GRACE—the Global Registry of Acute Coronary Events—emerged from an international collaboration among 250+ hospitals documenting outcomes in over 100,000 acute coronary syndrome patients beginning in 1999. The resulting risk model translates readily available clinical variables into predicted mortality probabilities.

Two complementary equations exist:

  • In-hospital model (Granger): Predicts death during the acute admission phase, typically within days to two weeks.
  • Six-month model (Fox): Extends prognostication to include early post-discharge events and complications.

ACS encompasses both ST-elevation myocardial infarction (STEMI) and non-ST-elevation presentations (NSTEMI and unstable angina), all carrying variable mortality depending on the extent of myocardial damage and haemodynamic stability.

GRACE Score Calculation

The calculator combines eight clinical variables, four of which require numerical entry (age in years, heart rate in beats per minute, systolic blood pressure in mmHg, and creatinine in mg/dL or μmol/L). The remaining four are categorical assessments: Killip classification, presence of cardiac arrest, ST-segment deviation, and elevated cardiac biomarkers.

Each variable contributes weighted points according to validated lookup tables. Once summed, the total score maps to a predicted mortality percentage.

In-hospital GRACE = Age points + HR points + sBP points + Creatinine
+ (39 × Cardiac arrest) + (28 × ST deviation) + (14 × Elevated enzymes)
+ Killip class

6-month GRACE = Age points + HR points + sBP points + Creatinine
+ (30 × Cardiac arrest) + (17 × ST deviation) + (13 × Elevated enzymes)
+ Killip class points

  • Age — Patient age in years; scored using age-stratified lookup values.
  • Heart rate (HR) — Resting pulse in beats per minute; reflects haemodynamic stress.
  • Systolic BP (sBP) — Systolic blood pressure in mmHg; hypotension increases risk substantially.
  • Creatinine — Serum creatinine concentration; renal impairment correlates with worse outcomes.
  • Cardiac arrest — Binary indicator (0 or 1); presence during presentation adds 39 points (in-hospital) or 30 points (6-month).
  • ST deviation — Binary indicator (0 or 1); ST-segment changes denote active ischaemia; weighted 28 or 17 points.
  • Elevated enzymes — Binary indicator (0 or 1); troponin or CK-MB elevation confirms myocardial necrosis; weighted 14 or 13 points.
  • Killip class — 1–4 scale reflecting clinical heart failure severity; ranges from 0 (no failure) to 3 (cardiogenic shock).

Killip Classification and Clinical Context

Killip class stratifies ACS patients by degree of left ventricular dysfunction and haemodynamic compromise:

  • Class I: No clinical heart failure. Lungs clear; normal jugular venous pressure.
  • Class II: Mild pulmonary congestion. Bilateral crackles or elevated JVP without systemic congestion.
  • Class III: Acute pulmonary oedema. Orthopnoea, crackles throughout lung fields, respiratory distress.
  • Class IV: Cardiogenic shock. Systolic pressure below 90 mmHg, signs of hypoperfusion (cold extremities, oliguria, altered mental status).

Progressive Killip class strongly predicts mortality; Class IV carries 50% in-hospital mortality compared to <5% for Class I.

Clinical Application Tips

Accurate GRACE scoring depends on careful data capture and understanding of model limitations.

  1. Timing of biomarker sampling — Troponin and CK-MB elevation may not be detected if blood is drawn within 3–6 hours of symptom onset. Serial sampling improves sensitivity; use the worst (highest) value for risk stratification.
  2. Blood pressure and medication effects — Systolic BP measured at presentation should reflect the patient's true haemodynamic state before aggressive fluid resuscitation or vasopressor therapy, which can artificially normalise readings and mask underlying shock.
  3. Creatinine in acute kidney injury — Baseline creatinine may not be available in acute settings. When only admission creatinine is known, consider that ACS itself can precipitate acute kidney injury; renal function may worsen post-admission, elevating risk beyond the initial GRACE score.
  4. Score interpretation with clinical judgment — GRACE is a predictive tool, not a treatment protocol. High-risk scores warrant aggressive revascularisation and intensive monitoring, but do not exclude patients from intervention based on age or baseline comorbidities alone.

Risk Stratification and Clinical Outcomes

GRACE scores are grouped into risk tiers that correlate with documented mortality rates:

  • Low risk (score < 108): In-hospital mortality typically < 1%; early discharge and outpatient follow-up acceptable.
  • Intermediate risk (108–140): Mortality 1–3%; standard intensive care unit monitoring and serial troponin.
  • High risk (> 140): Mortality > 3%; intensive monitoring, early coronary angiography, and consideration of mechanical support devices in Class IV cases.

The six-month model captures late events including recurrent ischaemia, heart failure decompensation, and arrhythmias. A high six-month score may justify more aggressive secondary prevention and closer outpatient surveillance even if in-hospital prognosis is favourable.

Frequently Asked Questions

Who should receive GRACE score assessment?

Any patient presenting with acute coronary syndrome—including STEMI, NSTEMI, and unstable angina—should undergo GRACE scoring within 24 hours of admission. The tool informs triage decisions in emergency departments, guides intensity of cardiac care unit monitoring, and helps clinicians discuss realistic prognosis with patients and families. It is most useful in the acute phase but can be recalculated at discharge to predict six-month risk.

What causes acute coronary syndrome?

ACS results from acute thrombotic occlusion or severe stenosis of a coronary artery, typically triggered by atherosclerotic plaque rupture. Underlying risk factors include hypertension, smoking, dyslipidaemia, diabetes, obesity, sedentary lifestyle, and family history of premature coronary disease. Emotional stress, extreme exertion, and respiratory infections can precipitate ACS in vulnerable individuals. Rarely, coronary artery dissection or vasospasm causes ACS without atherosclerosis.

How does creatinine affect the GRACE score?

Elevated serum creatinine—reflecting impaired renal function—independently predicts worse ACS outcomes and significantly increases the GRACE score. Renal insufficiency impairs medication clearance, worsens electrolyte disturbances, and indicates underlying systemic comorbidity. Even modest increases in creatinine (e.g., 1.2–1.5 mg/dL) add multiple points; values above 2.0 mg/dL sharply elevate mortality risk. Chronic kidney disease patients are at particular risk during the acute phase.

Can GRACE score predict long-term survival beyond six months?

The GRACE calculator provides validated estimates only for in-hospital and six-month mortality. Beyond six months, survival depends on secondary prevention adherence (medications, lifestyle modification, cardiac rehabilitation), repeated revascularisation rates, and development of chronic heart failure. The six-month prediction is valuable for counselling patients about the critical early period and motivating engagement in risk-reduction strategies.

What is the difference between the in-hospital and six-month GRACE models?

The in-hospital model uses coefficients optimised for mortality during acute admission (typically days 1–7), whereas the six-month model extends to 180 days and accounts for late complications and recurrent events. Both use the same eight variables but with different weighting—for example, cardiac arrest contributes 39 points in-hospital but only 30 points at six months, reflecting that surviving the acute phase favourably influences longer-term prognosis.

Should very elderly patients with high GRACE scores be excluded from revascularisation?

Age contributes points to the GRACE score but should never be the sole criterion for withholding treatment. Elderly patients benefit substantially from evidence-based interventions (antiplatelet therapy, beta-blockers, statins, coronary angiography with percutaneous coronary intervention when appropriate). A high GRACE score in an octogenarian may reflect comorbidities rather than age alone. Shared decision-making, frailty assessment, and functional status are more relevant than age-based eligibility rules.

health
ACFT Calculator

More health calculators (see all)

Body Frame Size Calculator Tramadol Dosage Calculator Period Calculator BMI Weight Loss Calculator Draw Length Calculator Urine Output Calculator Pearl Index Calculator BMI for Teens Calculator